75 results
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
3 Jun 24
Report of Foreign Private Issuer
8:05am
. I am excited to lead this study and look forward to initiating the trial.”
Dr. Oron has a long and successful track record of innovation. He
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
11 Apr 24
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
8:13am
: macrophage A Received regulatory authorization for Phase I/II trial, knee osteoarthritis.
4 | Nasdaq: ENLV DRIVING INNOVATION WITH BALANCED SCIENTIFIC
6-K
EX-99.1
ENLV
Enlivex Therapeutics Ltd
29 Mar 24
Report of Foreign Private Issuer
4:30pm
not been conclusively proven to be feasible and has no alternative future use.
Grants received from Israel Innovation Authority, Ministry of Industry … (represented by the Israeli Innovation Authority, the “IIA”), computed on the basis of proceeds from the sale or license of products for development supported
6-K
EX-99.2
ENLV
Enlivex Therapeutics Ltd
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
have funded our operations primarily through grants from the Israel Innovation Authority (the “IIA”) and the sale of equity and equity linked
6-K
EX-99.1
wdgfc
9 Nov 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
x3s5z8
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
qz4vw
1 Sep 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.2
ti050fknoh evcfwwbx
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
g71ci6f q6o6osm7gn7
16 Jun 23
Condensed Consolidated Financial Statements
4:30pm
6-K
EX-99.1
h7b7vhl
31 Mar 23
Report of Foreign Private Issuer
4:30pm
6-K
EX-10.1
qhs2eh yw
30 Dec 22
Report of Foreign Private Issuer
4:02pm
424B5
2spzq1inmrt3v 8mnd
30 Dec 22
Prospectus supplement for primary offering
4:01pm
6-K
EX-99.1
p1awv nsqp
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
feybqych 05yenp0pfi
2 Dec 22
Condensed Consolidated Financial Statements
4:15pm
6-K
EX-99.2
85m6yqc0fk jf
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.3
o47yy
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
hohhp8y qkriu15an
22 Aug 22
Condensed Consolidated Financial Statements
8:08am
6-K
EX-99.1
9yvm2r8mc pxhx3ur
6 Jul 22
Current report (foreign)
8:41am